PrimeRFP SCOUT · Federal Contract Profile

Genentech Usa (SA85BMHCTXK5)Federal contracts · 2 recompetes

Genentech Usa holds $136.1M in federal volume across 34 award actions, with 99% at Department of Health and Human Services (HHS). SCOUT tracks 2 incumbent recompetes — an estimated $120.1M returning to market over the next 24 months (High exposure). Primary work: Pharmaceutical Preparation; Medicinal And Botanical (100% prime). Obligations are down 170% year over year.

$136.1M

Federal Volume

Recompetes (24mo)

HHS

Top Agency · 99% firm-wide

34

Award Actions

Choose one — this changes what we ask next

Score my firm against Genentech Usa

Email me when a Genentech Usa recompete window opens.

Data through August 2026 · refreshed monthly · window Aug 2025 – Aug 2026

What they do

Capability

Service lines

PHARMACEUTICAL PREPARATION MANUFACTURING · MEDICINAL AND BOTANICAL MANUFACTURING

Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6505 DRUGS AND BIOLOGICALS

Where they win

2 agencies

% of firm-wide obligated ($136.1M) · all agencies

Department of Health and Human Services (HHS)$134.6M · 99%

Department of Defense (DOD)$1.6M · 1%

Recompete exposure: High · 2 in 24mo

Genentech Usa has an estimated $120.1M in contracts returning to market over the next 24 months.

Part of the GENENTECH USA INC corporate family · 2 entities

Metrics basis: local_db

Who buys from them

Agency buyer map

2 buyers

Department of Health and Human Services (HHS)11 awards · repeat buyer · $134.6M

Department of Defense (DOD)30 awards · repeat buyer · $1.6M

Recompete exposure & trajectory

Recompete exposure

High

Genentech Usa has an estimated $120.1M in contracts returning to market over the next 24 months. 1 within 6 months ($45.1M).

OSELTAMIVIR PHOSPHATE (TAMIFLU) 30MG AND 75MG CAPSULES →

PIID: 75A50325F80003 · Expires 2027-01-29

$45.1M

PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS →

PIID: 75A50325F80036 · Expires 2027-09-29

$75.0M

Trajectory

▼ Consolidating-170% YoYFY2025 vs FY2024

'23

'24

'25

“With competitive federal procurements, winning starts with strategically understanding the customer environment to the left of SAM.gov. This is what SCOUT does - a deeper and more precise understanding of what the…”

— Peter Lierni, Solutioneering

Explore another company

Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Genentech Usa hold?

Genentech Usa (UEI SA85BMHCTXK5) shows $136.1M across 34 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Genentech Usa have?

Genentech Usa shows $136.1M across 34 award actions. SCOUT tracks 2 incumbent recompetes ($120.1M) returning to market in the next 24 months.

Which agencies does Genentech Usa work with?

Genentech Usa’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (99%), Department of Defense (DOD) (1%).

What is the UEI for Genentech Usa?

The Unique Entity ID (UEI) for Genentech Usa is SA85BMHCTXK5.

Does Genentech Usa have contracts coming up for recompete?

Yes — SCOUT tracks 2 incumbent recompetes in the next 24 months (High exposure). Open the recompete section on this page for PIID-level timing.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.